Molecular Partners AG
SIX:MOLN

Watchlist Manager
Molecular Partners AG Logo
Molecular Partners AG
SIX:MOLN
Watchlist
Price: 3.4 CHF 1.8%
Market Cap: 137.3m CHF

Wall Street
Price Targets

MOLN Price Targets Summary
Molecular Partners AG

Wall Street analysts forecast MOLN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MOLN is 10.71 CHF with a low forecast of 6.06 CHF and a high forecast of 15.75 CHF.

Lowest
Price Target
6.06 CHF
78% Upside
Average
Price Target
10.71 CHF
215% Upside
Highest
Price Target
15.75 CHF
363% Upside
Molecular Partners AG Competitors:
Price Targets
300009
Anhui Anke Biotechnology Group Co Ltd
27% Upside
BCYC
Bicycle Therapeutics PLC
238% Upside
KRYS
Krystal Biotech Inc
75% Upside
TRDA
Entrada Therapeutics Inc
222% Upside
096530
Seegene Inc
25% Upside
IMMX
Immix Biopharma Inc
262% Upside
CYTK
Cytokinetics Inc
157% Upside
MRUS
Merus NV
71% Upside

Revenue
Forecast

Revenue Estimate
Molecular Partners AG

For the last 8 years the compound annual growth rate for Molecular Partners AG's revenue is -17%. The projected CAGR for the next 3 years is 91%.

-17%
Past Growth
91%
Estimated Growth
Estimates Accuracy
-26%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Molecular Partners AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

Net Income
Forecast

Net Income Estimate
Molecular Partners AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-16%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MOLN's stock price target?
Price Target
10.71 CHF

According to Wall Street analysts, the average 1-year price target for MOLN is 10.71 CHF with a low forecast of 6.06 CHF and a high forecast of 15.75 CHF.

What is Molecular Partners AG's Revenue forecast?
Projected CAGR
91%

For the last 8 years the compound annual growth rate for Molecular Partners AG's revenue is -17%. The projected CAGR for the next 3 years is 91%.

Back to Top